Related Experiment Video

Updated: Aug 14, 2026

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

Immuno-endocrine interactions in early pregnancy

G Chaouat1, E Menu, G Delage

  • 1Department of Obstetrics and Gynaecology, INSERM CJF 92-09, Hospital Béclére, Clamart, France.

Human Reproduction (Oxford, England)
|December 1, 1995
PubMed

Insights

Women with recurrent implantation failure show significantly lower leukaemia inhibiting factor (LIF) production. This factor is crucial for early pregnancy signalling and may be a target for improving IVF success rates.

Area of Science:

  • Reproductive Immunology
  • Maternal-Fetal Medicine
  • Cytokine Biology

Background:

  • Inflammatory cytokines play a critical role in early pregnancy implantation.
  • Leukaemia inhibiting factor (LIF) is a key cytokine involved in embryo implantation.
  • Recurrent implantation failure (RIF) affects numerous women undergoing in-vitro fertilization (IVF).

Purpose of the Study:

  • To investigate the production of LIF in women with RIF.
  • To explore the role of TH2 cytokines in normal pregnancy and spontaneous abortion models.
  • To assess potential therapeutic interventions for pregnancy loss.

Main Methods:

  • In-vitro culture of human decidual explants.
  • Measurement of LIF production in infertile women and controls.
  • Analysis of TH2 cytokine profiles in murine pregnancy models.
  • Evaluation of tau interferon treatment effects.

Main Results:

  • LIF production was significantly lower in women with RIF compared to normal.
  • TH2 cytokines, essential for normal pregnancy, were deficient in a murine model of spontaneous abortion.
  • Alloimmunization and tau interferon injection corrected the cytokine deficiency in the murine model.

Conclusions:

  • Reduced LIF production is a potential factor contributing to RIF in IVF.
  • TH2 cytokine deficiency may underlie spontaneous early pregnancy loss.
  • Tau interferon shows promise as a therapeutic agent for preventing pregnancy loss.

More Related Videos

Isolation of Primary Human Decidual Cells from the Fetal Membranes of Term Placentae07:37

Isolation of Primary Human Decidual Cells from the Fetal Membranes of Term Placentae

Published on: April 30, 2018

Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis07:46

Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis

Published on: October 13, 2023

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
An Overview of the Endocrine System01:10

An Overview of the Endocrine System

The endocrine system, a complex network of glands, orchestrates physiological balance within the body through the production and secretion of hormones. These hormones are chemical messengers in intercellular communication, acting as conduits between the secretory cells and distant target sites. They traverse the circulatory system by being released into the extracellular fluid, and their impact is specific to cells possessing receptors for a particular hormone.
The endocrine system collaborates...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral stimuli,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...